ATLANTA, Jan. 21, 2011 /PRNewswire/ — CardioMEMS,
Inc., an Atlanta-based medical technology company that has
developed and is commercializing a proprietary wireless sensing and
communication technology for the human body, has earned a Georgia
Bio (GaBio) 2011 Deal of the Year award. CardioMEMs was
recognized in the Strategic Partnership category for the
$60 million equity investment it secured from St. Jude Medical
(NYSE: STJ). The investment, which was made in September 2010,
followed the successful completion in 2010 of
CardioMEMS’ CHAMPION clinical study of its wireless,
implantable pressure monitor for heart failure.
Georgia Bio announced its 2011 Deal of the Year awards for
medical device and biopharmaceutical companies at the GaBio Annual
Awards Dinner held at Atlanta’s Fox Theater on January 20. The
annual awards recognize transactions by life sciences companies in
Georgia that are significant to the state’s industry development.
To reflect a broad range of activity in the midst of a challenging
economic environment, the awards are given in four categories:
public and private financings, strategic partnerships and
product launches.
“We are proud to be recognized by Georgia Bio,” said
Jay Yadav, M.D., founder and CEO of CardioMEMS and an
interventional cardiologist. “We have achieved our immediate goals
with the successful conclusion of the CHAMPION trial. As we
work toward the commercialization of this promising technology, we
are excited to partner with St. Jude Medical and its significant
expertise and focus in heart failure disease and cardiac rhythm
management.”
The Champion™ wireless HF sensor is an innovative
miniature device t
‘/>”/>
SOURCE
